A detailed history of Deka Bank Deutsche Girozentrale transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 100,000 shares of OCUL stock, worth $874,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100,000
Previous 100,000 -0.0%
Holding current value
$874,000
Previous $669,000 28.1%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 25, 2023

BUY
$4.6 - $7.64 $345,000 - $573,000
75,000 Added 300.0%
100,000 $505,000
Q1 2023

Apr 24, 2023

BUY
$2.79 - $6.27 $69,750 - $156,750
25,000 New
25,000 $137,000
Q4 2021

Feb 02, 2022

SELL
$6.16 - $12.07 $141,064 - $276,403
-22,900 Closed
0 $0
Q4 2020

Mar 12, 2021

BUY
$7.91 - $22.95 $181,139 - $525,555
22,900 New
22,900 $454,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $673M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.